Cargando…
Stroke Exacerbates Cancer Progression by Upregulating LCN2 in PMN-MDSC
Acute ischemic stroke (AIS) is common in patients with cancer, and mounting clinical evidence suggests that it may shorten the survival of cancer patients. But how stroke affects the progression of cancer remains unclear. We inoculated B16 tumor cells (2 × 10(5)) subcutaneously before distal middle...
Autores principales: | Huang, Tingting, Li, Yan, Zhou, Yuxi, Lu, Bingwei, Zhang, Yueman, Tang, Dan, Gan, Yu, He, Zhengzhou, Chen, Zengai, Yu, Weifeng, Li, Peiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050632/ https://www.ncbi.nlm.nih.gov/pubmed/32153594 http://dx.doi.org/10.3389/fimmu.2020.00299 |
Ejemplares similares
-
Upregulated TRAIL and Reduced DcR2 Mediate Apoptosis of Decidual PMN-MDSC in Unexplained Recurrent Pregnancy Loss
por: Li, Congcong, et al.
Publicado: (2020) -
PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease
por: Grassi, Germana, et al.
Publicado: (2021) -
LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression
por: Chai, ErQing, et al.
Publicado: (2019) -
GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC
por: Mabrouk, Nesrine, et al.
Publicado: (2023) -
Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma
por: Gondois-Rey, Françoise, et al.
Publicado: (2021)